Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mahon

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Choline levels in human peritoneal dialysateJ T Hjelle, M H Welch, T M Pavlina, et al.
JCO Precision Oncology|May 1, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral NeuropathyNicole Yeung, Tiffany Li, Hui-Ming Lin, et al.
BMJ Open|January 29, 2020
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)Tahlia Scheinberg, James Kench, Martin Stockler, et al.
Cancers|June 3, 2020
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate CancerDushan Miladinovic, Thomas Cusick, Kate L Mahon, et al.
Diabetes Care|March 12, 2015
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 monthsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
British Journal of Cancer|August 15, 2019
p53 nuclear accumulation as an early indicator of lethal prostate cancerDavid I Quinn, Phillip D Stricker, James G Kench, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2017
A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancerA Y Zhang, J S Grogan, K L Mahon, et al.
JCO Oncology Practice|September 24, 2020
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate CancerTahlia Scheinberg, Annabel Goodwin, Emilia Ip, et al.
Pediatric Diabetes|October 1, 2008
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial resultsJeffrey L Mahon, Jay M Sosenko, Lisa Rafkin-Mervis, et al.
European Urology|November 24, 2018
Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 TrialKate L Mahon, Wenjia Qu, Hui-Ming Lin, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1993
Choline levels in human peritoneal dialysateJ T Hjelle, M H Welch, T M Pavlina, et al.
JCO Precision Oncology|May 1, 2024
Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral NeuropathyNicole Yeung, Tiffany Li, Hui-Ming Lin, et al.
BMJ Open|January 29, 2020
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer)Tahlia Scheinberg, James Kench, Martin Stockler, et al.
Cancers|June 3, 2020
Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate CancerDushan Miladinovic, Thomas Cusick, Kate L Mahon, et al.
Diabetes Care|March 12, 2015
The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 monthsJay M Sosenko, Jay S Skyler, Craig A Beam, et al.
British Journal of Cancer|August 15, 2019
p53 nuclear accumulation as an early indicator of lethal prostate cancerDavid I Quinn, Phillip D Stricker, James G Kench, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2017
A prospective multicentre phase III validation study of AZGP1 as a biomarker in localized prostate cancerA Y Zhang, J S Grogan, K L Mahon, et al.
JCO Oncology Practice|September 24, 2020
Evaluation of a Mainstream Model of Genetic Testing for Men With Prostate CancerTahlia Scheinberg, Annabel Goodwin, Emilia Ip, et al.
Pediatric Diabetes|October 1, 2008
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial resultsJeffrey L Mahon, Jay M Sosenko, Lisa Rafkin-Mervis, et al.
European Urology|November 24, 2018
Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 TrialKate L Mahon, Wenjia Qu, Hui-Ming Lin, et al.
Pageof 10